Final Results of a Prospective Phase 2 Study of Adding Erlotinib to Chemoradiation for patients With Stage III Non-small Cell Lung Cancer

被引：0

作者：

Komaki, R. U. ^{[1
]}

Allen, P. K. ^{[1
]}

Wei, X. ^{[1
]}

Blumenschein, G. R. ^{[2
]}

XiMing, T. ^{[3
]}

Lee, J. J. ^{[3
]}

Welsh, J. W. ^{[1
]}

Wistuba, I. ^{[4
]}

Liu, D. D. ^{[3
]}

Meyn, R. ^{[5
]}

Hong, W. K. ^{[3
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Thorac Med Oncol, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期

关键词：

D O I：

10.1016/j.ijrobp.2017.06.1725

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3113

引用

页码：E470 / E470

页数：1

共 50 条

[1] Final Results of Prospective Phase II Study of Adding Erlotinib to Chemoradiation for patients with Stage III Non-Small-Cell Lung Cancer
Komaki, Ritsuko
Allen, Pamela
Wei, Xiong
Blumenschein, George
Tang, Xi Ming
Lee, J.
Welsh, James
Wistuba, Ignacio
Liu, Diane
Meyn, Ray
Hong, Waun
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S870 - S870
[2] VALUE OF ADDING ERLOTINIB TO THORACIC RADIATION THERAPY WITH CHEMOTHERAPY FOR STAGE III NON-SMALL CELL LUNG CANCER: A PROSPECTIVE PHASE II STUDY
Komaki, Ritsuko
Allen, Pamela
Wei, Xiong
Blumen-Schein, George
Tang, Xi Ming
Lee, J. Lee J.
Welsh, James W.
Wistuba, Ignacio Ivan
Liu, Diane D.
Hong, Waun K.
JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S136 - S137
[3] Phase II study of chemoradiation therapy and erlotinib for stage Ill non-small cell lung cancer
Komaki, Ritsuko U.
Wistuba, Ignacio
Tang, Xi Ming
Meyn, Raymond E.
Lee, J. Jack
Wei, Xiong
Allen, Pamela K.
O'Reilly, Michael S.
Welsh, James
Hong, Wuan Ki
CANCER RESEARCH, 2011, 71
[4] Chemoradiation for stage III non-small cell lung cancer
Ramella, Sara
Fiore, Michele
Iurato, Aurelia
Trodella, Luca E.
Trodella, Lucio
D'Angelillo, Rolando M.
EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
[5] Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer
Komaki, Ritsuko
Allen, Pamela K.
Wei, Xiong
Blumenschein, George R.
Tang, Ximing
Lee, J. Jack
Welsh, James W.
Wistuba, Ignacio I.
Liu, Diane D.
Hong, Waun Ki
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (02): : 317 - 324
[6] A phase I study of dasatinib with concurrent chemoradiation for stage III non-small cell lung cancer
Khurshid, Humera
Dipetrillo, Thomas
Ng, Thomas
Mantripragada, Kalyan
Birnbaum, Ariel
Berz, David
Radie-Keane, Kathy
Perez, Kimberly
Constantinou, Maria
Luppe, Denise
Schumacher, Andrew
Leonard, Kara
Safran, Howard
FRONTIERS IN ONCOLOGY, 2012, 2 : 7 - 11
[7] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Price, Katharine A. R.
Azzoli, Christopher G.
Gaspar, Laurie E.
SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
[8] Feasibility of Hypofractionated Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
Van Zyp, N. Van der Voort
Hashimzadah, M.
Kouwenhoven, E.
Maas, K.
Oosterhuis, W.
Walraven, I.
Belderbos, J.
Mast, M.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S633 - S633
[9] Chemoradiation in older patients with stage III non-small cell lung cancer (NSCLC)
Ng, Dawn M.
Sun, Alex
Coate, Linda
Ma, Clement
Bezjak, Andrea
Brade, Anthony
Burkes, Ronald L.
Cho, John
Feld, Ronald
Liu, Geoff
Shepherd, Frances
Leighl, Natasha B.
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S858 - S858
[10] O02.03 Value of Adding Erlotinib to Thoracic Radiation Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer: A Prospective Phase II Study
不详
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (01) : 6 - 6

← 1 2 3 4 5 →